Windlas Biotech Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Komal Gupta

Chief Executive Officer (CEO)

₹16.5m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	9.1yrs
Participación del CEO	n/a
Permanencia media de la dirección	4.6yrs
Promedio de permanencia en la Junta Directiva	4.5yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Komal Gupta

9.1yrs

Permanencia

₹16,530,000

Compensación

Mrs. Komal Gupta is the Chief Financial Officer of Windlas Biotech Limited since October 16, 2015 and serves as its Chief Executive Officer since February 08, 2023. She joined Windlas Biotech on October 16...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Komal Gupta	CFO & CEO	9.1yrs	₹16.53m	sin datos
Ananta Panda	Company Secretary & Compliance Officer	3.6yrs	₹2.52m	sin datos
Ashok Windlass	Whole-Time Director	no data	₹15.60m	62.51% ₹ 12.5b
Hitesh Windlass	MD & Executive Director	4.6yrs	₹17.50m	0.000010% ₹ 2.0k
Manoj Windlass	Joint MD & Executive Director	4.6yrs	₹17.50m	0.000030% ₹ 6.0k
Pawan Sharma	Executive Director	no data	₹5.07m	sin datos
Mohammed Aslam	President of Sales & Marketing	no data	sin datos	sin datos
Om Sule	Site Quality Head	4.9yrs	sin datos	sin datos

4.6yrs

Permanencia media

55.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 543329 se considera experimentado (4.6 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Ashok Windlass	Whole-Time Director	23.8yrs	₹15.60m	62.51% ₹ 12.5b
Hitesh Windlass	MD & Executive Director	16.8yrs	₹17.50m	0.000010% ₹ 2.0k
Manoj Windlass	Joint MD & Executive Director	18.6yrs	₹17.50m	0.000030% ₹ 6.0k
Pawan Sharma	Executive Director	5.4yrs	₹5.07m	sin datos
Gaurav Gulati	Non-Executive Independent Director	3.5yrs	₹540.00k	sin datos
Vivek Dhariwal	Non-Executive Independent Chairman	3.5yrs	₹380.00k	sin datos
Srinivasan Venkataraman	Non-Executive Independent Director	3.5yrs	₹450.00k	sin datos
Prachi Windlass	Non-Executive Director	3.5yrs	sin datos	0.000010% ₹ 2.0k

4.5yrs

Permanencia media

49yo

Promedio de edad

Junta con experiencia: La junta directiva de 543329 se considera experimentada (4.5 años de antigüedad promedio).

Windlas Biotech Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Windlas Biotech Limited, Annual General Meeting, Sep 24, 2024

Windlas Biotech Limited, Annual General Meeting, Sep 24, 2024

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Less than half of directors are independent

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

Recent updates

Second quarter 2025 earnings released: EPS: ₹7.49 (vs ₹6.75 in 2Q 2024)

New minor risk - Share price stability

Windlas Biotech Limited to Report Q2, 2025 Results on Nov 12, 2024

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

Windlas Biotech Limited Approves Final Dividend for the Financial Year 2023-24

Dividend increased to ₹5.50

Windlas Biotech Limited, Annual General Meeting, Sep 24, 2024

Windlas Biotech Limited, Annual General Meeting, Sep 24, 2024

First quarter 2025 earnings released: EPS: ₹6.47 (vs ₹5.79 in 1Q 2024)

Windlas Biotech Limited to Report Q1, 2025 Results on Aug 13, 2024

Investor sentiment improves as stock rises 17%

Full year 2024 earnings released: EPS: ₹27.97 (vs ₹19.70 in FY 2023)

Now 21% overvalued after recent price rise

Windlas Biotech Limited to Report Q4, 2024 Results on May 20, 2024

Now 21% overvalued after recent price rise

Now 20% overvalued after recent price rise

Third quarter 2024 earnings released: EPS: ₹7.26 (vs ₹4.23 in 3Q 2023)

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Windlas Biotech Limited to Report Q3, 2024 Results on Feb 08, 2024

Investor sentiment improves as stock rises 22%

Second quarter 2024 earnings released: EPS: ₹6.75 (vs ₹5.59 in 2Q 2023)

Windlas Biotech Limited to Report First Half, 2024 Results on Nov 08, 2023

Windlas Biotech Limited Approves Final Dividend for the Financial Year 2022-23

Upcoming dividend of ₹4.00 per share at 1.1% yield

Windlas Biotech Limited, Annual General Meeting, Sep 12, 2023

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: ₹5.79 (vs ₹4.50 in 1Q 2023)

Windlas Biotech Limited to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings released: EPS: ₹19.70 (vs ₹18.58 in FY 2022)

Windlas Biotech Limited Recommends Dividend

Windlas Biotech Limited Appoints Komal Gupta as the Chief Executive Officer

Third quarter 2023 earnings released: EPS: ₹4.23 (vs ₹3.81 in 3Q 2022)

Less than half of directors are independent

Windlas Biotech Limited (BSE:543329) announces an Equity Buyback for INR 250 million worth of its shares.

Second quarter 2023 earnings released: EPS: ₹5.59 (vs ₹4.11 in 2Q 2022)

Windlas Biotech Limited Declares A Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited Proposes Final Dividend for the Financial Year 2021-22

Windlas Biotech Limited, Annual General Meeting, Sep 19, 2022

First quarter 2023 earnings released: EPS: ₹4.50 (vs ₹3.67 in 1Q 2022)

Windlas Biotech Limited to Report Q1, 2023 Results on Aug 04, 2022

The Board of Directors of Windlas Biotech Limited, At Their Meeting Held on May 12, 2022, Approves the Dividend of INR 3.5 Per Share

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

First quarter 2022 earnings released: EPS ₹3.67 (vs ₹0.25 in 1Q 2021)

Investor sentiment improved over the past week

Less than half of directors are independent

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad